These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16012862)

  • 1. Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx.
    Tateya I; Hirano S; Kojima H; Omori K; Shoji K; Mitsumori M; Nagata Y; Ito J
    Eur Arch Otorhinolaryngol; 2006 Feb; 263(2):144-8. PubMed ID: 16012862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
    Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionation.
    Okubo M; Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Tachibana I; Koike R; Nishikawa T; Mori K
    Jpn J Clin Oncol; 2010 Oct; 40(10):944-8. PubMed ID: 20534687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Ann Otol Rhinol Laryngol; 2006 Oct; 115(10):727-32. PubMed ID: 17076093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
    Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
    Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.
    Manzo R; Ravo V; Murino P; Morra A; Panetti G; Laudati A; Prisco A; Panelli G; Muto P
    Tumori; 2010; 96(4):577-81. PubMed ID: 20968137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer.
    Haugen H; Johansson KA; Mercke C
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):109-19. PubMed ID: 11777628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated radiotherapy and surgery compared to standard radiotherapy in early glottic cancer.
    Kim KN; Dyer MA; Qureshi MM; Shah NK; Grillone GA; Faden DL; Jalisi SM; Truong MT
    Am J Otolaryngol; 2020; 41(5):102544. PubMed ID: 32505989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic carbon dioxide laser surgery for glottic cancer recurrence after radiotherapy: oncological results.
    Ansarin M; Planicka M; Rotundo S; Santoro L; Zurlo V; Maffini F; Alterio D; Cattaneo A; Chiesa F
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1193-7. PubMed ID: 18086959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiation therapy with docetaxel (DOC) for laryngeal preservation in T2N0M0 glottic squamous cell carcinomas.
    Furusaka T; Matsuda A; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2013 Jan; 133(1):99-112. PubMed ID: 23106412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.